
Wuhan Wansheng Biotechnology
Ipamorelin
Finnrick tested 8 samples of Ipamorelin (GHS agonist) from Wuhan Wansheng Biotechnology between 11 Aug 2025 and 10 Dec 2025. Test scores average over 6, no score below 5, and at least 6 tests warrant a confident Finnrick Rating of B (Good).
Finnrick Rating™
Wuhan Wansheng Biotechnology
Ipamorelin
Tested 8 Samples
Last test 10 Dec 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Ipamorelin tests from top-rated vendors:
All Ipamorelin tests from Wuhan Wansheng Biotechnology
Samples are tested in commercial labs
Tests Count
8
Scores
AVGMINMAX
Last
10 Dec 2025
First
11 Aug 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 10 Dec 2025 | View | 5mg | 5mg | 99.80% | IP5(0) | (no data) | Lab G | Public | ||
| 2 Dec 2025 | View | 10mg | 10.4mg | +4.0% | 99.80% | WWB 11/2025 | White Label / Black Crimp / Clear Cap | Lab G | Public | |
| 14 Nov 2025 | View | 10mg | 10.9mg | +9.0% | 99.90% | HQD|IP10-1 | No Label / Black Crimp / Clear Cap | Lab G | Public | |
| 23 Oct 2025 | View | 5mg | 5.04mg | +0.8% | 98.59% | (no batch ID) | No Label / Silver Crimp / Black Cap | Lab E | Public | |
| 3 Oct 2025 | View | 5mg | 4.93mg | -1.4% | 99.76% | (no batch ID) | No Label / Silver Crimp / Purple Cap | Lab E | Public | |
| 25 Sep 2025 | View | 5mg | 4.89mg | -2.2% | 99.76% | 07-2025 | No Label / Silver Crimp / Clear Red Cap | Lab E | Public | |
| 1 Sep 2025 | View | 10mg | 9.1mg | -9.0% | 99.88% | (no batch ID) | No Label / Silver Crimp / Violet Cap | Lab F | Public | |
| 11 Aug 2025 | View | 10mg | 8.73mg | -12.7% | 99.84% | (no batch ID) | No Label / Silver Crimp / Black Cap | Lab E | Public | |